HWC Options Flash Bullish as Shorts Ease After Earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Hancock Whitney Corporation heads into the post-earnings week with an unusual combination: short interest fading from its April highs while options traders turn distinctly bullish — two signals pulling in the same direction.
The options market is the loudest signal right now. Put/call ratio has dropped to 0.13, roughly 2.4 standard deviations below its 20-day average of 0.18 — making this one of the most call-heavy readings of the past year. That level of skew toward calls suggests options participants are positioned for further upside, not hedging against a pullback. The move is notable coming just days after the Q1 earnings release on April 21, where the stock fell roughly 2.9% in the session and held most of that loss over the subsequent week.
Short interest reinforces the cautiously constructive tone. SI has pulled back to 8.6% of the free float from a recent peak near 9.1% on April 22-23, a decline of around 5% on the week. Looking further back, shorts had climbed from roughly 8.3% in early April to above 9% around the earnings date, then unwound quickly once the print was out. Borrowing costs remain cheap at 0.43% APR — down nearly 10% on the week — and borrow availability is loose, with no material tightening evident over the 30-day window. The lending market offers no squeeze pressure at current positioning levels.
The Street is broadly constructive. All four covering analysts carry positive ratings — a mix of Buy, Overweight, and Strong Buy — with the mean price target at $77.63, implying roughly 16% upside to the April 29 close of $66.63. Piper Sandler lifted its target to $80 following the earnings release, maintaining its Overweight rating. The bull case centres on net interest margin expansion of 12-15 basis points by Q4 2026, accelerated hiring of revenue producers, and an asset-sensitive balance sheet that benefits from any rate hike cycle. Bears focus on yield-curve compression and the risk that an economic slowdown pushes up nonperforming assets. Valuation looks undemanding: the stock trades at roughly 10.2x earnings and 1.1x book — both multiples expanded about 10% over the past month as the price recovered from tariff-shock lows. The factor profile adds nuance: the forward EPS growth rank is strong at the 86th percentile, and analyst recommendation spread is in the 99th percentile, but EPS surprise history ranks in just the 4th percentile — the company has a track record of missing rather than beating estimates.
The most striking item in the insider ledger is the CEO. John Hairston sold a combined 63,453 shares across two transactions in early February at prices between $72.81 and $74.36, raising roughly $4.7 million. That selling occurred at prices well above where the stock trades today. Smaller director purchases in late March — in the low-$60s — add modest countervailing context but are de minimis in size. The net 90-day insider position is positive in share count terms, but that reflects awards rather than open-market conviction buying.
The next scheduled earnings event is July 14. Between now and then, what to watch is whether call-side enthusiasm in options persists beyond the immediate post-earnings window, and whether short interest continues drifting lower or re-builds as macro uncertainty around regional bank credit quality resurfaces — peer TCBI fell nearly 4% on the week, the weakest in the group, while ZION gained 1%, underscoring how divergent sentiment across regional banks remains.
Stocks in this article
See the live data behind this article on ORTEX.
Open HWC on ORTEX →How this article was generated
- Generated
- 30 Apr 2026, 06:04
- Data as of
- 30 Apr 2026, 06:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.